[The role of prolactin in endometrial lesions].
The Authors examine serum levels of HPRL in basal conditions and after TRH and sulpiride test in 15 patients with endometrial lesions (hyperplasia) and in 15 patients with endometrial adenocarcinoma included in a age range between 44 and 62 years, in which 7 patients present obesity, 10 patients present hypertension and 2 patients are hyperglycemic. The same examination is carried out in a control group of 30 healthy patients. Then the 15 patients with adenocarcinoma and 3 patients with adenomatosa hyperplasia are subjected to surgery and they estimate HPRL levels in endometrium. The results prove that there is no correlation between HPRL plasma levels and endometrium lesions and between endometrium HPRL. The Authors conclude that HPRL does not play a significant role in the pathogenesis of endometrial lesions; use of HPRL plasma levels as a marker of endometrial lesions is not possible.
Tolino
A
A
II Facoltà di Medicina e Chirurgia, Università degli Studi Federico II, Napoli.
Di Serio
C
C
Caracciolo
G B
GB
Tartaglia
E
E
Riccio
S
S
D000230:Adenocarcinoma / Q000097:blood*; D000293:Adolescent; D000328:Adult; D004714:Endometrial Hyperplasia / Q000097:blood*; D016889:Endometrial Neoplasms / Q000097:blood*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*
D011388:Prolactin
Ruolo della prolattina nelle lesioni endometriali.